Giuseppe Curigliano and Barbara Jereczek-Fossa
May 7, 2025, 15:53
Giuseppe Curigliano and Barbara Jereczek-Fossa have been elected to lead ESMO and ESTRO – IEO European Institute of Oncology
IEO European Institute of Oncology shared a post on LinkedIn:
“The multidisciplinary approach, based on the collaboration between oncologists and radio-oncologists, is confirmed as the key to successfully addressing the challenges of contemporary oncology.
Our Profs. Giuseppe Curigliano – Deputy Scientific Director and Director of the Development of New Drugs for Innovative Therapies Division – and Barbara Jereczek-Fossa, – Director of Radiotherapy, respectively elected to lead the first two oncology societies in Europe: the European Society for Medical Oncology (ESMO) and the European Society for Radiotherapy and Oncology (ESTRO), tell us about it on Corriere della Sera.
More posts featuring IEO European Institute of Oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 8, 2025, 20:27
Jul 8, 2025, 18:55